The Latest Cardiac and Vascular News
SAN FRANCISCO, May 05, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2022. First Quarter 2022 Financial Highlights Revenue of $92.4 million, a 24.3% increase […]
Achieved revenue of $77.2 million in the first quarter 2022 versus $71.1 million in the first quarter of 2021, an increase of 8.6% on a GAAP basis and 11.2% on a non-GAAP constant currency basis ATLANTA, May 5, 2022 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced its […]
Conference Call Scheduled for 4:30 PM Eastern Time Today WALTHAM, Mass., May 5, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today provided a business update and reported financial results for the first quarter ended March […]
CHICAGO, May 6, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) awarded grants to three researchers its 2022 Annual Meeting. ISHLT grants fund research to improve the care of patients with advanced heart and lung disease through transplantation, mechanical circulatory support (MCS), and innovative therapies. “I am absolutely […]
WEST CHESTER, Pa., May 6, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the expansion of their Scientific Advisory Board with the addition of Dr. Dai Yamanouchi. Dr Yamanouchi, a Vascular Surgeon, is an Associate Professor at the University of Wisconsin School of Medicine and Adjunct Professor at Tokyo Medical and Dental University also […]
Signs definitive merger agreement with Cend Therapeutics along with immediate investment and collaboration agreements Maintains strong financial position while advancing and expanding development portfolio Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., May 05, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the […]
Announced positive topline results from Phase 2 SEISMiC study of istaroxime in early cardiogenic shock Late-breaker presentation of additional SEISMiC study results at the European Society of Cardiology (ESC) Heart Failure Conference. Management to host investor call following the presentation on May 23 WARRINGTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) […]
INDIANAPOLIS–(BUSINESS WIRE)–Modular Devices Acquisition, LLC (Modular Devices), a leading provider of mobile cath labs and mobile cleanrooms, today announced the acquisition of Cardiac Services Mobile, Inc. (Cardiac Services Mobile), a mobile cath lab company out of Nashville, TN that serves the US markets. The acquisition builds on Modular Devices’ position […]
Management to host conference call following announcement of Phase 2/3 TREASURE data in May CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2022. In anticipation of the announcement in May of topline data from Athersys’ partner, HEALIOS K.K. (Healios), for its […]
Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by decline in worldwide COVID-only testing revenues to $214 million from $474 million in the prior year GAAP diluted EPS of $1.50; adjusted diluted EPS of $3.18 Company raises mid-point of […]
